BCG Article: The COVID-19 pandemic has exacted an enormous professional and personal toll on health care professionals (HCPs) and is changing the way they work. Some of these changes are likely to be permanent. For biopharma companies, this means interacting with HCPs very differently in the post-COVID-19 reality. Source: https://www.bcg.com/publications/2020/what-doctors-want-and-what-this-means-for-the-biopharma-industry
Comments are closed.
|
AboutIn this blog we review important trends and insights from global thought leaders including McKinsey, BCG Categories
All
Archives
September 2024
|